Blockade of β-adrenergic receptor signaling improves cancer vaccine efficacy through its effect on naive CD8+ T-cell priming
Clara Daher, Lene Vimeux, Ralitsa Stoeva, Elisa Peranzoni, Georges Bismuth, Emmanuel Donnadieu, Nadège Bercovici, Alain Trautmann, Vincent Feuillet
This study shows that blocking β-adrenergic receptor signaling enhances cancer vaccine efficacy by improving naive CD8+ T-cell priming, without affecting tumor-infiltrating CD8+ T-cell reactivity.
bioRxiv · Dec 16, 2018 · PreprintImmunology